l glutathione ulcerative colitis Advances in the Treatment of Colitis—From Conventional Therapies to Targeted Biologics and Small Molecules Full article: Hydrogen Regulates Ulcerative

2017], another confirmatory phase III placebo-controlled trial showed that edaravone treatment resulted in a statistically significant change in ALS FRS-R primary endpoint over 24 weeks in a subset of ALS patients (2017

Methionine is a metabolic dependency of tumor-initiating cells

Targeting lipophagy in MASLD Multiple compounds, including MSDC-0602K, PF-05221304, IVA337, saroglitazar, and curcumin, modulate mTORC1 signaling to restore lipophagic flux and are progressing through phase II clinical trials (Tables 1 and 2)

INDICATION :- Anaemia Lack of energy Weakness Vitamin B12 Deficiency DOSE & ROUTE OF ADMINISTRATION :- By I.M route only